Ciudad de la Habana, Cuba

Belkis Gonzalez Barrios



 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Belkis Gonzalez Barrios: Innovator in Cancer Treatment

Introduction

Belkis Gonzalez Barrios is a notable inventor based in Ciudad de la Habana, Cuba, recognized for her significant contributions to the field of Molecular Pharmacology. With a focus on developing novel peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors, she has made groundbreaking strides in cancer research.

Latest Patents

Belkis has been granted a patent for her innovative work titled "Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors." This patent highlights her discovery of eleven cyclic peptides that not only inhibit the CKII phosphorylation domain but also exhibit cytotoxic effects on HPV-16 transformed cells, paving the way for potential targeted cancer therapies.

Career Highlights

Belkis currently works at the Centro de Ingeniería Genética y Biotecnología, where her research is focused on advancing therapeutic options for cancer patients. Her expertise in molecular pharmacology has enabled her to be at the forefront of peptide development, specifically targeting oncogenic types of HPVs. With her innovative approach, she aims to enhance the efficacy of cancer treatments through the use of her peptides.

Collaborations

Throughout her career, Belkis has collaborated with esteemed colleagues such as Silvio Ernesto Perea Rodriguez and Osvaldo Reyes Acosta. These partnerships underscore the collaborative nature of scientific research and the importance of teamwork in achieving innovative breakthroughs in cancer treatment.

Conclusion

Belkis Gonzalez Barrios exemplifies the spirit of innovation in the field of cancer research. Her patented work on peptides for treating HPV-associated tumors signifies a promising advance in molecular pharmacology. As she continues her research at the Centro de Ingeniería Genética y Biotecnología, her contributions will undoubtedly impact the future of cancer treatment and enhance the lives of countless patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…